Gray Strategic Advisors, LLC provides strategic consulting services to the biotechnology industry.   The president, Mary Ann Gray, Ph.D., has had over 12 years experience as a scientist in academia and industry as well as 11 years of Wall Street experience as a sell-side analyst and a portfolio manager.   §         We can facilitate your strategic review process and help formulate goals that the whole company can work towards.   §         Business development can be a time consuming process.  We can act as a coordinator of your business development efforts, supplying ideas, gathering data and making contacts.   §         Pipeline review and prioritization often need an impartial eye.  We can provide an objective point of view particularly for oncology and anti-infectives, our areas of scientific expertise.   §         Our scientific training also enables us to conduct due diligence on products and companies for investors or potential partners.     §         Although we are not an investor relations firm, we can help you get ready to meet with investors by reviewing your slides and critiquing your presentation.  If necessary, we can refer you to other experts for more detailed work.   §         We also maintain contact with an extensive network of other professionals in investor relations, financial services, legal services and various medical and business specialties.  We can refer you to our sources or we can coordinate these services to make sure that your needs are served.   Please contact Gray Strategic Advisors, LLC for a proposal designed to fit your needs:   Mary Ann Gray, Ph.D. Gray Strategic Advisors, LLC 201 West 70th Street, 23K New York, NY 10023 917-273-2550 mag@grayadvisors.com